Industry / Estonia

Krka In Court...Again

July 2010 | Industry Trend Analysis

Printable version
Bookmark

If the legal action against Krka in Estonia is contained, it will have little impact on the company's future revenues.

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

Baltic Recession Sparks Epidemiological Concerns

Industry / Estonia BMI View: There is an inextricable link between economic performance, healthcare and epidemiology. Severe economic downturns are likely to raise the burden on healthcare, particularly for communicable...

April 2010

Pharmaceutical Market Should Outperform Baltic Peers

Industry / Estonia BMI forecasts that pharmaceutical sales growth in Estonia will rebound in 2010, though macroeconomic factors presage a less positive growth dynamic over the next decade. Data from the State Agency of...

April 2010

Pharmacists Required To Offer Cheapest Generic Alternatives

Industry / Estonia BMI believes that the use of generic drugs in Estonia is set to increase, following the introduction of a decree aimed at promoting the substitution of generics for prescription drugs. Building on current...

March 2010

Pharmaceutical Market Unaffected By Budget Cuts

Industry / Estonia The Estonian drug market should continue to grow strongly in 2008 as the Estonian government decides against cutting drug reimbursement in its supplementary state

May 2008

Cambrex Snaps Up Estonian API Firm

Companies / Estonia US healthcare firm Cambrex has acquired, through its Swedish subsidiary Cambrex Karlskoga, Estonian active pharmaceutical ingredient (API) producer ProSyntest, as it seeks as to strengthen its European...

January 2008